Navigation Links
FDA Approves PREZISTA®/ritonavir Once-Daily Dosing for HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
Date:12/13/2010

olytic hepatitis) has been reported with PREZISTA/ritonavir. During the clinical development program (N=3063), hepatitis has been reported in 0.5% of patients receiving combination therapy with PREZISTA/ritonavir. Patients with preexisting liver dysfunction, including chronic active hepatitis B or C, have an increased risk for liver function abnormalities, including severe hepatic adverse events

Post-marketing cases of liver injury, including some fatalities, have been reported. A causal relationship with PREZISTA/ritonavir therapy has not been establishedAppropriate laboratory testing should be conducted prior to initiating therapy with PREZISTA/ritonavir and patients should be monitored during treatment. Increased AST/ALT monitoring should be considered in patients with underlying chronic hepatitis, cirrhosis, or in patients who have pretreatment elevations of transaminases, especially during the first several months of PREZISTA/ritonavir treatment. Evidence of new or worsening liver dysfunction (including clinically significant elevation of liver enzymes and/or symptoms such as fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly) in patients on PREZISTA/ritonavir should prompt consideration of interruption or discontinuation of treatment


  • Severe Skin Reactions:  Severe skin reactions (0.4%), accompanied by fever and/or elevations of transaminases in some cases, Stevens-Johnson Syndrome (<0.1%), and toxic epidermal necrolysis (post-marketing experience) have been reported in patients receiving PREZISTA/ritonavir.  Discontinue PREZISTA/ritonavir immediately if signs or symptoms of severe skin reactions develop (including, but not limited to, severe rash or rash accompanied with fever, general malaise, fatigue, muscle or join aches, blisters, oral lesions, conjunctivitis, hepatitis and/or eosinophilia)  

  • In clinical trials (N=3063), rash (all grades, generally m
    '/>"/>

    SOURCE Tibotec Therapeutics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
    2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
    3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
    4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
    5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
    6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
    7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
    8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
    9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
    10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
    11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... , July 23, 2014 PositiveID ... Fla. , is an emerging player in ... systems for bio-threat detection and rapid medical testing. ... M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed ... Security ("DHS") Science & Technology directorate, and $30 ...
    (Date:7/23/2014)... , July 23, 2014  When it comes to ... is ready to roll out the red carpet. ... an influx of HAL 9000-like robots into our human sphere. ... now, there,s a pressing need to apply new technologies to ... worldwide market for medical robotics is expected to increase from ...
    (Date:7/23/2014)... South Korea , July 23, 2014  Mezzion ... clinical program to evaluate the use of udenafil to ... for single ventricle heart defects. The clinical program will ... representatives of the Pediatric Heart Network (PHN), a multi-center ... and Blood Institute (NHLBI) of the National Institutes of ...
    Breaking Medicine Technology:PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2
    ... Feb. 23, 2011 Colorcon, Inc., today announced ... product line to include PVA-based, high-productivity systems designed ... the EU. European Commission Directive ... use of existing additives in certain food supplement ...
    ... SAN DIEGO, Feb. 23, 2011 Thomas, McNerney & ... invests in life science and medical technology companies, will ... to San Diego.  Thomas, McNerney partner Pratik Shah, Ph.D. ... being held in San Diego. "Southern California ...
    Cached Medicine Technology:Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego 2
    (Date:7/23/2014)... experts have joined together for the first time to ... millions of people worldwide suffering from the condition. , ... cause irreversible joint damage if left untreated. , PsA ... which causes a red, scaly rash, and affects approximately ... , Around one in five go on to develop ...
    (Date:7/23/2014)... new study in East Asian women has identified three ... cancer. The research, led by Vanderbilt University investigators, was ... , While breast cancer is one of the most ... genetic risk factors for the disease have focused on ... genetic heritage and environmental exposures between East Asian women ...
    (Date:7/23/2014)... 2014 On July 21, 2014, My Positive ... Jack Tracey for an episode that spoke about the group ... asks Tracey to talk some about the formation of the ... mission, it was started right here in Charleston, originally it ... to help survivors of sexual abuse. Their purpose has shifted ...
    (Date:7/23/2014)... 23, 2014 The Circuelle Foundation ... academic institutions uncovering the importance of breast self-exams ... need for breast self-exams is contradictory and can ... today for keeping this healthy ritual. , “Women ... the significance of breast self-exams and becoming breast ...
    (Date:7/23/2014)... Psoriasis is an autoimmune disease that ... the skin—but this disease is not just skin deep. ... some cancers, certain types of arthritis, or ulcerative colitis. ... it occurs in families and is not contagious. It ... symptoms must be managed at all times to relieve ...
    Breaking Medicine News(10 mins):Health News:Psoriatic arthritis patients need better screening, warns panel of experts 2Health News:Vanderbilt-led study identifies genes linked to breast cancer in East Asian women 2Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2Health News:Historical and Current Research Points to Importance of Breast Self-Exams 2Health News:MedicationDiscountCard.com Makes Tazorac Discount Cards For Psoriasis Sufferers 2
    ... and SAN JOSE, Calif., March 31 ... today announced that it has entered into a contract ... embedded computing engine for Authentidate,s joint ... initial delivery of units, Authentidate will have the option ...
    ... in incremental Medicare spending in FY 2006ATLANTA, March ... in-hospital mortality and some complications among Medicare beneficiaries ... time, rates of infection and acute respiratory distress ... surgery increased. Those were among the findings of ...
    ... Key Step in Ongoing Research to Replicate Insulin-Producing Function ... , SANTA BARBARA, Calif., March 31 A ... pancreas for patients with diabetes has been achieved, according ... Diabetes Technology & Therapeutics .Researchers at the ...
    ... patient safety, says Dr. FriedbergCORONA DEL MAR, Calif., ... (ASA) April ,Anesthesiology, reports of 2,211 patient deaths ... ,TOO MUCH, anesthesia)," says Dr. Friedberg. "Had the ... (BAMs), FDA approved and available since 1996, many, ...
    ... Trusted Name in Home Health Care Provides Extensive Services ... and most experienced provider of in home support and ... its San Francisco location. Interim HomeStyle Services first ... non-medical home care services to help people remain independent ...
    ... Dr. Andrew Cheng, ENT, Offers Help to Tinnitus Sufferers , ... Edison, NJ (PRWEB) March ... which there is no cure. In fact, an estimated 50 million people (according ... in the ears) that ranges from mild to severe - so severe ...
    Cached Medicine News:Health News:Eurotech and Authentidate Enter into a Contract for Embedded Computer for Home-Based Medical Device 2Health News:Eurotech and Authentidate Enter into a Contract for Embedded Computer for Home-Based Medical Device 3Health News:Number of Revascularization Procedures, Related In-Hospital Mortality and Some Complications Decline, While Rates of Infection and Acute Respiratory Distress Syndrome (ARDS) Following Coronary Artery Bypass Graft (CABG) Surgery Increase 2Health News:Number of Revascularization Procedures, Related In-Hospital Mortality and Some Complications Decline, While Rates of Infection and Acute Respiratory Distress Syndrome (ARDS) Following Coronary Artery Bypass Graft (CABG) Surgery Increase 3Health News:Researchers Successfully Create Computer-Simulated Model for Evaluating Artificial Pancreas 2Health News:Researchers Successfully Create Computer-Simulated Model for Evaluating Artificial Pancreas 3Health News:American Society of Anesthesiologists - 2,211 Patient Deaths From OVER Medication 2Health News:Nation's Largest Home Care Provider Welcomes New Management Team to San Francisco Office 2Health News:Ear Health News: Natural Treatments to Ease Tinnitus Intensity 2
    ... wound filler and Tegagel hydrogel wound ... dressings specially formulated to help provide ... shown to enhance wound healing. The ... needs for management of non-draining, minimally ...
    ... complete physician preference card system as well ... all the supply management requirements of the ... combined with a broad array of inventory ... and operating suite supply and charge capture ...
    ... ErecAid® Esteem™ External Vacuum Therapy System restores ... impotent men. Non-invasive and low cost vacuum ... of desirable outcome", makes it the ideal ... Vacuum Therapy System causes penile rigidity that ...
    Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
    Medicine Products: